Showing 641-650 of 5319 results for "".
Diversity and Equity in Dermatology
https://practicaldermatology.com/topics/practice-management/diversity-and-equity-in-dermatology/23456/SPF Does Not Interfere with Vitamin D Synthesis: Assessing New Evidence
https://practicaldermatology.com/topics/skin-cancer-photoprotection/spf-does-not-interfere-with-vitamin-d-synthesis-assessing-new-evidence/23200/Recent research pokes holes in the argument that SPF impairs natural vitamin D synthesis.Your Comprehensive Guide to Energy-Based Devices
https://practicaldermatology.com/topics/practice-management/your-comprehensive-guide-to-energy-based-devices/23146/Digital Innovation to the Rescue: The Future of Electronic Prior Authorization in Dermatology
https://practicaldermatology.com/topics/practice-management/digital-innovation-to-the-rescue-the-future-of-electronic-prior-authorization-in-dermatology/20467/Adopting new technology to reduce paperwork, costs, and burnout as well as improve patient care.Emerging Business Concept: The Acne Treatment Center
https://practicaldermatology.com/topics/practice-management/emerging-business-concept-the-acne-treatment-center/20700/What if there was a practice devoted solely to the treatment of acne and acne scars?Estate Planning Essentials for Physicians of All Ages
https://practicaldermatology.com/topics/practice-management/estate-planning-essentials-for-physicians-of-all-ages/23258/Things to do now to prepare.Emollient-Based Therapy for AD: A Potential Role for Rebalancing the Microbiome
https://practicaldermatology.com/issues/supplements/emollient-based-therapy-for-ad-a-potential-role-for-rebalancing-the-microbiome/23136/Building A Practice’s Value: Establishing the Model
https://practicaldermatology.com/topics/practice-management/building-a-practices-value-establishing-the-model/23098/There are multiple opportunities for dermatology practices to potentially add value, but there is no one-size-fits-all formula.AbbVie's Skyrizi Approved, Brooke Shields Endorses SculpSure
https://practicaldermatology.com/topics/psoriasis/dermwire-tv-abbvies-skyrizi-approved-brooke-shi/19607/Skyrizi, an interleukin-23 inhibitor from AbbVie, is FDA approved for the treatment of moderate to severe plaque psoriasis in adults. Brooke Shields is the face of the new “Be strong. Be sexy. Be confident” campaign for SculpSure, from Hologic’s Cynosure. The Noah Worcester Dermatological Society anThe Importance of Employee Engagement
https://practicaldermatology.com/topics/general-topics/the-importance-of-employee-engagement/20639/The most valuable asset to your medical practice is not what you think.